Document Detail


Antibacterial properties of xanthine oxidase in human milk.
MedLine Citation:
PMID:  11022933     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Formula-fed babies contract gastroenteritis more than breast-fed babies, which is of concern to mothers who cannot breastfeed or, as with HIV-infected mothers, are discouraged from breastfeeding. The ability of endogenous breastmilk xanthine oxidase to generate the antimicrobial radical nitric oxide has been measured and its influence on the growth of Escherichia coli and Salmonella enteritides examined. Breastmilk, but not formula feed, generated nitric oxide. Xanthine oxidase activity substantially inhibited the growth of both bacteria. An important natural antibiotic system is missing in formula feeds; the addition of xanthine oxidase may improve formula for use when breastfeeding is not a safe option.
Authors:
C R Stevens; T M Millar; J G Clinch; J M Kanczler; T Bodamyali; D R Blake
Related Documents :
11021413 - Infant feeding: a critical look at infant formulas.
15081493 - Production of a novel polygalacturonic acid bioflocculant rea-11 by corynebacterium glu...
8127543 - Examination of factors contributing to the risk of cesarean delivery in women with gest...
Publication Detail:
Type:  Letter; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Lancet     Volume:  356     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-10-19     Completed Date:  2000-10-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  829-30     Citation Subset:  AIM; IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / isolation & purification,  pharmacology*
Drug Interactions
Escherichia coli / drug effects,  growth & development
Female
Humans
Hydrogen Peroxide / pharmacology
Hypoxanthine / pharmacology
Milk, Human / enzymology*,  metabolism
Nitric Oxide / biosynthesis
Salmonella enteritidis / drug effects,  growth & development
Xanthine Oxidase / isolation & purification,  metabolism,  pharmacology*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 10102-43-9/Nitric Oxide; 68-94-0/Hypoxanthine; 7722-84-1/Hydrogen Peroxide; EC 1.17.3.2/Xanthine Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
Next Document:  Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males.